Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) SHZ
4.13
-0.05999996(-1.43%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Luoxin Pharmaceuticals Group Stock Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3388
First IPO Date
April 15, 2016
Key Executives
| Name | Title | Pay | Year Born |
| Xian Chen | Financial Manager & Financial Director | 0 | 1983 |
| Zhenteng Liu | GM & Chairman | 0 | 1986 |
| Fengsheng Han | Board Secretary | 0 | 1975 |
| Hongxing Zhang | Accounting Supervisor | 0 | N/A |
Description
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. is based in Linyi, China.
